Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.

Vaccinations with the Johnson & Johnson jab paused at several sites earlier this week after an unusual number of people experienced adverse reactions, but the CDC says there’s no cause for concern.

From a loss of taste to dementia, infectious agents cause an array of neurological symptoms.

The European Medicines Agency emphasizes that the benefits of the jab in protecting against COVID-19 still far outweigh the risks.

Designing multicolor flow cytometry panels to characterize immunological changes observed in COVID-19 patients.

A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.

Stanford University researchers determined the code from spare drops in discarded vials of the COVID-19 vaccine and published it on GitHub.

Many major biopharmaceutical companies are developing or acquiring drugs that target the NLRP3 inflammasome, a large intracellular complex that researchers say can spark inflammation and stoke diseases of lifestyle and aging.

In the armpit lymph nodes of people who had received the mRNA vaccine against SARS-CoV-2, researchers found germinal centers needed to generate long-lived antibody-making cells.